Previous 10 | Next 10 |
Acquisition to support accelerated commercialization of Koligo’s KYSLECEL ® , a personalized islet cell therapy available in the U.S. for chronic and recurrent acute pancreatitis Goal to rapidly advance KT-PC-301, an autologous cell therapy ...
Gainers: AcelRx Pharmaceuticals (ACRX) +17%, Cardiff Oncology (CRDF) +16%, Humanigen (HGEN) +14%, Medicenna Therapeutics (MDNA) +11%, Orgenesis (ORGS) +7%.Losers: iCAD (ICAD) -21%, Pieris Pharmaceuticals (PIRS) -19%, Legend Biot...
GERMANTOWN, Md., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGTs), today announced that CEO, Vered Caplan, will p...
GERMANTOWN, Md., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGTs), has entered into a Services Agreement with...
Provides update on COVID-19 therapeutic programs Reports cash and cash equivalents of $97.5 million as of June 30, 2020 GERMANTOWN, Md., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a pioneering, g...
Orgenesis (NASDAQ: ORGS ) has collaborated with Educell Ltd., a European cell therapy company. More news on: Orgenesis Inc., Healthcare stocks news, Read more ...
GERMANTOWN, Md., July 14, 2020 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a pioneering global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs),...
Orgenesis (NASDAQ: ORGS ) added to the Russell 3000 Index, effective after the market open June 29 . More news on: Orgenesis Inc., Soleno Therapeutics, Inc., Cidara Therapeutics, Inc., Healthcare stocks news, Read more ...
GERMANTOWN, Md., June 29, 2020 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a pioneering, global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs)...
Orgenesis (NASDAQ: ORGS ) has entered into a preliminary, non-binding term sheet with Leidos (NYSE: LDOS ), to develop, and potentially obtain FDA marketing approval of Orgenesis’ Ranpirnase for the treatment of patients with SARS-CoV-2, the virus that causes COVID-19. More n...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 2.7% to $127.255 on volume of 88,797,787 shares Ascent Solar Technologies Inc (ASTI) rose 9.6% to $0.1183 on volume of 88,651,038 shares Crown Electrokinetics Corp. (CRKN) fell 19.0% to $0.040499 on volu...